Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Research & Development (2016 - 2026)

Biomerica's Research & Development history spans 17 years, with the latest figure at $178000.0 for Q1 2026.

  • Quarterly results put Research & Development at $178000.0 for Q1 2026, down 17.97% from a year ago — trailing twelve months through Feb 2026 was $835000.0 (down 19.4% YoY), and the annual figure for FY2025 was $1.0 million, down 31.39%.
  • Research & Development for Q1 2026 was $178000.0 at Biomerica, down from $193000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $495419.0 in Q2 2022 to a low of $178000.0 in Q1 2026.
  • The 5-year median for Research & Development is $343000.0 (2024), against an average of $327318.8.
  • The sharpest move saw Research & Development surged 63.81% in 2022, then crashed 37.62% in 2024.
  • Year by year, Research & Development stood at $462000.0 in 2022, then decreased by 10.82% to $412000.0 in 2023, then tumbled by 37.62% to $257000.0 in 2024, then dropped by 24.9% to $193000.0 in 2025, then dropped by 7.77% to $178000.0 in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $178000.0, $193000.0, and $212000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.